IP Library Patent Application 10896481
Patent Application
App. No. 10/896,481

Method for filtering blood in a vessel with helical elements

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/896,481
Abstract

A method for capturing an embolus within a vessel of a patient's body includes the steps of providing a device having at least one helix made of a mesh material. The at least one helix has a plurality of turns helically arranged around a longitudinal axis. The mesh material has a plurality of pores therein wherein the pores have a size ≧120 μm. The device is placed within the vessel of the patient's body by moving the device from a collapsed state to an expanded state.

Claims (82)

1 . A method for capturing an embolus within a vessel of a patient's body, the method comprising the steps of:

providing a device comprising at least one helix made of a mesh material,

the at least one helix having a plurality of turns helically arranged around a longitudinal axis, the mesh material having a plurality of pores therein, the pores having a size ≧120 μm; and

placing the device within the vessel of the patient's body.

2 . The method according to claim 2 , wherein the device is placed within the vessel of the patient's body by moving the device from a collapsed state to an expanded state when placed within a vessel.

3 . The method according to claim 2 , further comprising anchoring the device to an inner wall of the vessel.

4 . The method according to claim 3 , further comprising anchoring the device to an inner wall of the vessel using a plurality of barbs.

5 . The method according to claim 2 , wherein the device is placed within the vessel through use of a delivery catheter.

6 . The method according to claim 1 , further comprising eluting at least one drug from the device.

7 . The method according to claim 6 , further comprising eluting at least one cytostatic drug from the device.

8 . The method according to claim 7 , further comprising eluting a rapamycin from the device.

9 . The method according to claim 6 , further comprising eluting at least one cytotoxic drug from the device.

10 . The method according to claim 9 , further comprising eluting paclitaxel from the device.

11 . The method according to claim 2 , further comprising moving the device from the collapsed state to the expanded state using a self-expanding material.

12 . The method according to claim 11 , further comprising moving the device from the collapsed state to the expanded state using a shape memory material.

13 . The method according to claim 12 , further comprising moving the device from the collapsed state to the expanded state using a metal alloy.

14 . The method according to claim 13 , further comprising moving the device from the collapsed state to the expanded state using a nickel titanium material.

15 . The method according to claim 2 , further comprising moving the device from the collapsed state to the expanded state using a stainless steel material.

16 . The method according to claim 11 , further comprising moving the device from the collapsed state to the expanded state using a polymer material.

17 . The method according to claim 16 , further comprising moving the device from the collapsed state to the expanded state using a biodegradable polymer material.

18 . The method according to claim 17 , further comprising moving the device from the collapsed state to the expanded state using a bioabsorbable polymer material.

19 . A method for capturing an embolus within a vessel of a patient's body, the method comprising the steps of:

providing a device comprising at least one helix made of a mesh material,

the at least one helix having a plurality of turns helically arranged around a longitudinal axis, the mesh material having a plurality of pores therein, the pores having a size ≧120 μm, the pores varying in size from a larger size at one end of the at least one helix to a smaller size at an opposite end of the at least one helix; and

placing the device within the vessel of the patient's body.

20 . The method according to claim 19 , wherein the device is placed within the vessel of the patient's body by moving the device from a collapsed state to an expanded state when placed within a vessel.

21 . The method according to claim 20 , further comprising anchoring the device to an inner wall of the vessel.

22 . The method according to claim 21 , further comprising anchoring the device to an inner wall of the vessel using a plurality of barbs.

23 . The method according to claim 20 , wherein the device is placed within the vessel through use of a delivery catheter.

24 . The method according to claim 19 , further comprising eluting at least one drug from the device.

25 . The method according to claim 24 , further comprising eluting at least one cytostatic drug from the device.

26 . The method according to claim 25 , further comprising eluting a rapamycin from the device.

27 . The method according to claim 24 , further comprising eluting at least one cytotoxic drug from the device.

28 . The method according to claim 27 , further comprising eluting paclitaxel from the device.

29 . The method according to claim 20 , further comprising moving the device from the collapsed state to the expanded state using a self-expanding material.

30 . The method according to claim 29 , further comprising moving the device from the collapsed state to the expanded state using a shape memory material.

31 . The method according to claim 30 , further comprising moving the device from the collapsed state to the expanded state using a metal alloy.

32 . The method according to claim 31 , further comprising moving the device from the collapsed state to the expanded state using a nickel titanium material.

33 . The method according to claim 20 , further comprising moving the device from the collapsed state to the expanded state using a stainless steel material.

34 . The method according to claim 29 , further comprising moving the device from the collapsed state to the expanded state using a polymer material.

35 . The method according to claim 34 , further comprising moving the device from the collapsed state to the expanded state using a biodegradable polymer material.

36 . The method according to claim 35 , further comprising moving the device from the collapsed state to the expanded state using a bioabsorbable polymer material.

37 . A method for trapping an embolus within a vessel of a patient's body, the method comprising the steps of:

providing a device comprising a plurality of mesh panels movable from a collapsed state to an expanded state when placed within a vessel, the mesh panels forming a plurality of turns helically arranged around a longitudinal axis when in the expanded state, the mesh panels having a plurality of pores therein, the pores having a size ≧120 μm; and

placing the device within the vessel of the patient's body.

38 . The method according to claim 37 , wherein the device is placed within the vessel of the patient's body by moving the mesh panels of the device from a collapsed state to an expanded state when placed within a vessel.

39 . The method according to claim 38 , further comprising anchoring the device to an inner wall of the vessel.

40 . The method according to claim 39 , further comprising anchoring the device to an inner wall of the vessel using a plurality of barbs.

41 . The method according to claim 38 , wherein the device is placed within the vessel through use of a delivery catheter.

42 . The method according to claim 37 , further comprising eluting at least one drug from the device.

43 . The method according to claim 42 , further comprising eluting at least one cytostatic drug from the device.

44 . The method according to claim 43 , further comprising eluting a rapamycin from the device.

45 . The method according to claim 42 , further comprising eluting at least one cytotoxic drug from the device.

46 . The method according to claim 45 , further comprising eluting paclitaxel from the device.

47 . The method according to claim 38 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a self-expanding material.

48 . The method according to claim 47 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a shape memory material.

49 . The method according to claim 48 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a metal alloy.

50 . The method according to claim 49 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a nickel titanium material.

51 . The method according to claim 38 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a stainless steel material.

52 . The method according to claim 47 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a polymer material.

53 . The method according to claim 52 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a biodegradable polymer material.

54 . The method according to claim 53 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a bioabsorbable polymer material.

55 . A method for trapping an embolus within a vessel of a patient's body, the method comprising the steps of:

providing a device comprising a plurality of mesh panels movable from a collapsed state to an expanded state when placed within a vessel, the mesh panels forming a plurality of turns helically arranged around a longitudinal axis in a double helix arrangement when in the expanded state, the mesh panels having a plurality of pores therein, the pores having a size ≧120 μm; and

placing the device within the vessel of the patient's body.

56 . The method according to claim 55 , wherein the device is placed within the vessel of the patient's body by moving the mesh panels of the device from a collapsed state to an expanded state when placed within a vessel.

57 . The method according to claim 56 , further comprising anchoring the device to an inner wall of the vessel.

58 . The method according to claim 57 , further comprising anchoring the device to an inner wall of the vessel using a plurality of barbs.

59 . The method according to claim 56 , wherein the device is placed within the vessel through use of a delivery catheter.

60 . The method according to claim 55 , further comprising eluting at least one drug from the device.

61 . The method according to claim 60 , further comprising eluting at least one cytostatic drug from the device.

62 . The method according to claim 61 , further comprising eluting a rapamycin from the device.

63 . The method according to claim 60 , further comprising eluting at least one cytotoxic drug from the device.

64 . The method according to claim 63 , further comprising eluting paclitaxel from the device.

65 . The method according to claim 56 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a self-expanding material.

66 . The method according to claim 65 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a shape memory material.

67 . The method according to claim 66 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a metal alloy.

68 . The method according to claim 67 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a nickel titanium material.

69 . The method according to claim 56 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a stainless steel material.

70 . The method according to claim 65 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a polymer material.

71 . The method according to claim 70 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a biodegradable polymer material.

72 . The method according to claim 71 , further comprising moving the mesh panels of the device from the collapsed state to the expanded state using a bioabsorbable polymer material.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2007
From: CORDIS CORPORATION
To: WYETH
Reel/Frame 020234/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2004
From: NIERMANN, VOLKER
To: CORDIS CORPORATION
Reel/Frame 016046/0333 →